The company’s current independent pharmacy member base represents over 50% of the United States pharmaceutical market within that vertical Actively used in all 50 states with over 11,700 pharmacies in its network, serving around 15 million patients indirectly through these networks of pharmacies Pharmaceutical supplies and services provider Trxade Group (NASDAQ: MEDS) benefited from an … Continue reading “Trxade Group, Inc. (NASDAQ: MEDS) Ending Q3 Strong with Increased Investor Exposure”
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, recently had the opportunity to showcase its growing medical technology accomplishments at multiple virtual investor conferences. Trxade Group CEO Suren Ajjarapu took the company’s message well beyond physical borders to virtual summits in the month of September, providing insight into the dynamic capabilities and … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Shines Spotlight on Dynamic Platform Capabilities”
Pressing need for efficient drug procurement, delivery as costs rise Trxade platform speeds up delivery, cuts costs Such efficiencies crucial to keeping America’s independent pharmacies alive Around half of 24,000 independent pharmacies have already signed on These days, critics of the U.S. health-care system may be tempering their censure. After all, the sector has proved … Continue reading “Trxade Group Inc. (NASDAQ: MEDS) Pharmaceutical Supply Chain Trading Platform Gives Independent Drugstores a New Lease on Life”
Pharmaceutical industry services provider Trxade Group Inc. presented an overview of the company’s structure and strategy at this month’s LD 500 invitational microcap investor summit The investor summit was a virtual gathering place during the ongoing pandemic, providing brand and industry information through webcasts to more than 20,000 attendees representing hundreds of companies Trxade Group … Continue reading “Trxade Group, Inc. (NASDAQ: MEDS) Showcases Prescription Affordability Efforts During Virtual Investor Summit”
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, has achieved a growing distinction and web-based presence, offering transparency in pharmaceutical purchasing. The company’s flagship Bonum+ platform provides subscribers with access to drug prices and supply availability, enabling them to make informed product ordering decisions. A recent article discussing this quotes Trxade Group … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Offers ‘Radical Price Transparency’ to Maximize Savings, Lower Costs of Pharmaceuticals”
Trxade Group Inc. (NASDAQ: MEDS) is an integrated drug-procurement, delivery and health care platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states, with the central mission of making health care services affordable and accessible. Founded in 2010, Trxade Group is comprised … Continue reading “Trxade Group Inc. (NASDAQ: MEDS) Featured in Virtual Coverage of The Wall Street Investor Forum”
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health-care platform, on Thursday announced that it will participate in the following virtual investor conferences during the month of September 2020: the Colliers Institutional Investor Conference on September 10 and the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16. Trxade Group CEO Suren … Continue reading “NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Present at September Virtual Investor Conferences”
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, achieved a record $6.6 million in revenues for the second quarter of 2020, representing a 244% increase compared to the same period last year. In large part, the company attributes the boost to a critical and opportune strategy. A recent article discussing this reads, … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Delivers Crucial PPE, Drives Increased Revenues in Q2 2020”
Trxade Group Inc. (NASDAQ: MEDS) is an integrated drug procurement and delivery and health care platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making health care services affordable and accessible. Founded in 2010, Trxade Group … Continue reading “Trxade Group Inc. (NASDAQ: MEDS) Starts Presentation at The LD 500”
Trxade Group Inc. is a supplies and services innovator for the pharmaceutical industry, working to keep small retailers competitive with large chains and costs accessible for end-use patients Trxade Group has seen its brand grow significantly during the past year, adding a 244 percent year-over-year increase to its quarterly revenues during the spring The company … Continue reading “Trxade Group, Inc. (NASDAQ: MEDS) to Boost Brand Through Participation in LD 500 Virtual Investor Conference”
